JPS6338198B2 - - Google Patents
Info
- Publication number
- JPS6338198B2 JPS6338198B2 JP20834285A JP20834285A JPS6338198B2 JP S6338198 B2 JPS6338198 B2 JP S6338198B2 JP 20834285 A JP20834285 A JP 20834285A JP 20834285 A JP20834285 A JP 20834285A JP S6338198 B2 JPS6338198 B2 JP S6338198B2
- Authority
- JP
- Japan
- Prior art keywords
- acetylputretscine
- concentration
- acetylputrescine
- oxidase
- polyamines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 28
- 102000004316 Oxidoreductases Human genes 0.000 claims description 15
- 108090000854 Oxidoreductases Proteins 0.000 claims description 15
- 229920000768 polyamine Polymers 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- PFNFFQXMRSDOHW-UHFFFAOYSA-N Spermine Natural products NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 13
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 10
- KLZGKIDSEJWEDW-UHFFFAOYSA-N N-acetylputrescine Chemical compound CC(=O)NCCCCN KLZGKIDSEJWEDW-UHFFFAOYSA-N 0.000 description 10
- 239000008363 phosphate buffer Substances 0.000 description 10
- ATHGHQPFGPMSJY-UHFFFAOYSA-N Spermidine Natural products NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 238000004040 coloring Methods 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- 229940063675 spermine Drugs 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000003992 Peroxidases Human genes 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 229940063673 spermidine Drugs 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- MQTAVJHICJWXBR-UHFFFAOYSA-N N(1)-acetylspermidine Chemical compound CC(=O)NCCCNCCCCN MQTAVJHICJWXBR-UHFFFAOYSA-N 0.000 description 3
- FONIWJIDLJEJTL-UHFFFAOYSA-N N(8)-acetylspermidine Chemical compound CC(=O)NCCCCNCCCN FONIWJIDLJEJTL-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- -1 urine Substances 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 2
- GUNURVWAJRRUAV-UHFFFAOYSA-N N(1)-acetylspermine Chemical compound CC(=O)NCCCNCCCCNCCCN GUNURVWAJRRUAV-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- DDSLGZOYEPKPSJ-UHFFFAOYSA-N 4-acetamidobutanal Chemical compound CC(=O)NCCCC=O DDSLGZOYEPKPSJ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明はアセチルプトレツシンオキシダーゼを
アセチルプトレツシンを含む系に作用させ、発生
する過酸化水素の量を測定することにより、アセ
チルプトレツシンの濃度を定量する方法に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for quantifying the concentration of acetylputretscine by causing acetylputretscine oxidase to act on a system containing acetylputretscine and measuring the amount of hydrogen peroxide generated. It is related to.
ポリアミン例えばプトレツシンH2N
(CH2)4NH2、スペルミジンH2N(CH2)4NH
(CH2)3NH2、スペルミンH2N(CH2)3NH
(CH2)4NH(CH2)3NH2などは、動物をはじめ、
植物、細菌などあらゆる生命細胞の構成成分とし
て生物界に広く分布し、細胞の分裂、増殖及び生
化学的背景をなす核酸の代謝に関与している物質
として知られている。 Polyamines such as putrescine H 2 N
( CH2 ) 4NH2 , spermidine H2N ( CH2 ) 4NH
( CH2 ) 3NH2 , spermine H2N ( CH2 ) 3NH
(CH 2 ) 4 NH (CH 2 ) 3 NH 2 etc. are found in animals,
It is widely distributed throughout the living world as a component of all living cells such as plants and bacteria, and is known to be involved in cell division, proliferation, and the metabolism of nucleic acids, which form the biochemical background.
ところで、近年ガン患者の尿中ポリアミン量が
正常人よりも多いことが報告され〔「キヤンサー、
リサーチ(Chncer Rosearch)」、第31巻、第
1555〜1558ページ〕、多くの研究者により尿、血
液、リンパ液などいわゆる体液中のポリアミン量
とガン疾患との関係についての研究がなされてき
たが、その後シユヨウ組織の増殖に際してもポリ
アミン代謝の高進化が認められ、ポリアミン排泄
量の変動がガン患者の病状の推移を反映すること
が明らかになり、臨床的にガンの診断及びガンの
治瘉状態を知る上で、ポリアミンの定量が重量と
なつてきた。 By the way, in recent years it has been reported that the amount of polyamines in the urine of cancer patients is higher than that of normal people.
Research (Chancer Rosearch), Volume 31, No.
[pages 1555-1558], many researchers have conducted research on the relationship between the amount of polyamines in so-called body fluids such as urine, blood, and lymph and cancer diseases. It has become clear that fluctuations in polyamine excretion reflect changes in the disease state of cancer patients, and the quantification of polyamines has become important in clinically diagnosing cancer and understanding the state of cancer cure. Ta.
従来、ポリアミンの定量法としては、ガスクロ
マトグラフイーによる方法(「クリニカルケミス
トリ(Clinical Chemistry)」、第19巻、第904〜
907ページ〕、アミノ酸分析計による方法(「フエ
ブス・レターズ(FEBS Letters)」、第46巻、第
305〜307ページ〕、高速液体クロマトグラフイー
による方法(「ジヤーナル・オブ・クロマトグラ
フイー(J.Chromatography)」、第145巻、第141
〜146ページ〕などの化学的方法が主体となつて
いたが、これらの化学的方法は迅速性にに欠ける
上に、酸などによる加水分解後、さらにポリアミ
ン類を測定可能な誘導体に変換する前処理を必要
とするため操作がはん雑になるなど実用上多くの
不便を有していた。 Conventionally, methods for quantifying polyamines include gas chromatography (Clinical Chemistry, Vol. 19, No. 904-
907 pages], Amino Acid Analyzer Method (FEBS Letters, Vol. 46, No.
Pages 305-307], High Performance Liquid Chromatography Method (J. Chromatography, Vol. 145, No. 141)
However, these chemical methods lack rapidity and require additional processing after hydrolysis with acids and before converting polyamines into measurable derivatives. This method has many practical inconveniences, such as requiring processing and making operations complicated.
他方、酵素の特異的作用を利用して、遊離ポリ
アミンを定量する方法(特公昭56−36918号公
報)、スペルミジンとスペルミンを定量する方法
(特公昭56−21398号公報)、スペルミン、スペル
ミジン及びプトレツシンを定量する方法(特開昭
50−9492号公報)などが提案されている。これら
の酵素的方法は、化学的方法のように特に誘導体
にするための前処理を施す必要はなく、また迅速
性の点でもかなり改善された好ましい方法である
が、これらの方法はいずれも遊離ポリアミンとし
ての定量を目的としたものであるため、アセチル
ポリアミンが混在した場合には塩酸などによる加
水分解や酵素による脱アセチル化を施し、これら
を遊離ポリアミンに変換させなければならないの
で操作がはん雑となる上に、アセチルポリアミン
を直接に定量することができない。 On the other hand, a method for quantifying free polyamines using the specific action of an enzyme (Japanese Patent Publication No. 56-36918), a method for quantifying spermidine and spermine (Japanese Patent Publication No. 56-21398), spermine, spermidine, and putretsucine. Method for quantifying
50-9492) have been proposed. Unlike chemical methods, these enzymatic methods do not require special pretreatment to make derivatives, and are preferred methods as they are considerably improved in terms of rapidity. Since the purpose is to quantify polyamines, if acetyl polyamines are present, they must be hydrolyzed with hydrochloric acid or deacetylated with enzymes to convert them to free polyamines, which makes the operation difficult. In addition to being complicated, acetyl polyamines cannot be directly quantified.
しかるに、最近の研究によれば人の尿中ポリア
ミンはその大部分がアセチルプトレツシンであ
り、この増減がガンの診断及びガンの治瘉状態を
知る上で有効であることが明らかになりつつあ
り、アセチルプトレツシンの定量をより簡便に行
いうる方法の出現がこの分野において広く要望さ
れるようになつてきた。 However, according to recent research, the majority of polyamines in human urine are acetylputretscine, and it is becoming clear that this increase or decrease is effective in diagnosing cancer and determining the status of cancer cure. There has been a wide demand in this field for a method that can more easily quantify acetylputretscine.
本発明者らは、このような事情に鑑み、アセチ
ルプトレツシンを迅速、簡便かつ正確に定量しう
る方法を開発すべく鋭意研究を重ねた結果、アセ
チルプトレツシンを含む系にアセチルプトレツシ
ンオキシダーゼを作用させ、生成する過酸化水素
の濃度を測定することにより、この目的を達成し
うることを見出し、この知見に基づいて本発明を
なすに至つた。 In view of these circumstances, the present inventors have conducted intensive research to develop a method that can quickly, easily, and accurately quantify acetylputretscine. It was discovered that this object could be achieved by allowing synoxidase to act and measuring the concentration of hydrogen peroxide produced, and based on this knowledge, the present invention was accomplished.
すなわち、本発明は、新規な酵素であるアセチ
ルプトレツシンオキシダーゼをアセチルプトレツ
シンを含む系に作用させ、生成した過酸化水素の
濃度を測定することにより、アセチルプトレツシ
ンの濃度を定量する方法を提供するものである。 That is, the present invention quantifies the concentration of acetylputretscine by causing a novel enzyme, acetylputretscine oxidase, to act on a system containing acetylputretscine and measuring the concentration of hydrogen peroxide produced. The present invention provides a method.
アセチルプトレツシンオキシダーゼは、例えば
アスペルギルス・オリゼ(Aspergillus oryzae)
IAM2682により生産される文献未載の新規な酵
素であり、次に述べる方法にて製造されうる。ア
スペルギルス・オリゼIAM2682(東京大学応用微
生物研究所より入手)を培地組成NaNO30.1%、
KH2PO40.1%、MgSO40.05%、KC10.05%、グル
コース3.0からなる培地に接触し、28℃、48時間
培養し、こうして得られた種培養液をグルコース
0.1%、KH2PO40.1%、K2HPO40.15%、
MgSO40.02%、アセチルプトレツシン0.2%から
なる培地に加え、48時間本培養を行なつた。培養
終了後、ろ過により菌体を集め、0.01Mリン酸緩
衝液(PH6.8)で洗浄し、同一緩衝液に懸濁後、
ダイノーミルで破壊した。この破壊液より遠心分
離7000rpm、20分で上澄を得、該抽出液を直ちに
0.01Mリン酸緩衝液(PH6.8)で緩衝化された
DEAE、セルロースに通し、アセチルプトレツシ
ンオキシダーゼを吸着させ、ついで0.1Mリン酸
緩衝液(PH6.8)で洗浄し、直線濃度勾配法によ
り溶出する。溶出された活性画分は50%〜90%飽
和の硫安濃度で硫安分画を行なつた後、0.01Mリ
ン酸緩衝液(PH6.0)で透析する。ついで透析酵
素液を同一緩衝液で緩衝化したヒドロキシアパタ
イトカラムに通液し、活性区分を吸着せしめ、
0.01Mリン酸緩衝液(PH6.0)で洗浄し、さらに
0.01〜0.2Mリン酸緩衝液(PH6.0)による直線濃
度勾配法で活性画分を溶離せしめる。該溶離液を
90%飽和硫安により濃縮後、セフアデツクスG−
200による分離を行ない精製酵素を得た。本精製
酵素は以下に示す理化学的性質を有するものであ
る。 Acetylputretscine oxidase is produced, for example, by Aspergillus oryzae.
This is a novel enzyme produced by IAM2682 that has not been described in any literature, and can be produced by the method described below. Aspergillus oryzae IAM2682 (obtained from the Institute of Applied Microbiology, University of Tokyo) was cultured with a medium composition of NaNO 3 0.1%,
Contact with a medium consisting of KH 2 PO 4 0.1%, MgSO 4 0.05%, KC 10.05%, glucose 3.0 and culture at 28°C for 48 hours, and the seed culture thus obtained was
0.1%, KH2PO4 0.1 %, K2HPO4 0.15 %,
Main culture was carried out for 48 hours in addition to a medium consisting of 0.02% MgSO 4 and 0.2% acetylputretscine. After culturing, the bacterial cells were collected by filtration, washed with 0.01M phosphate buffer (PH6.8), suspended in the same buffer,
Destroyed it with a dyno mill. A supernatant was obtained from this disrupted solution by centrifugation at 7000 rpm for 20 minutes, and the extract was immediately collected.
Buffered with 0.01M phosphate buffer (PH6.8)
Pass through DEAE and cellulose to adsorb acetylputrescine oxidase, then wash with 0.1M phosphate buffer (PH6.8) and elute using a linear concentration gradient method. The eluted active fraction is subjected to ammonium sulfate fractionation at an ammonium sulfate concentration of 50% to 90% saturation, and then dialyzed against 0.01M phosphate buffer (PH6.0). Next, the dialyzed enzyme solution was passed through a hydroxyapatite column buffered with the same buffer solution, and the active fraction was adsorbed.
Wash with 0.01M phosphate buffer (PH6.0), and then
The active fraction is eluted using a linear concentration gradient method using 0.01-0.2M phosphate buffer (PH6.0). The eluent
After concentration with 90% saturated ammonium sulfate, Sephadex G-
Purified enzyme was obtained by separation using 200 ml. This purified enzyme has the following physical and chemical properties.
(1) 作用;アセチルプトレツシンに作用して、そ
の1モルよりも1モルの4−アセチルアミノブ
タナールと1モルの過酸化水素を生成する。(1) Action: Acts on acetylputrescine to produce 1 mole of 4-acetylaminobutanal and 1 mole of hydrogen peroxide.
(2) 基質特異性;アセチルプトレツシンに対して
は作用するがスペルミン、スペルジン、プトレ
ツシン、N−アセチルスペルミン、N1−アセ
チルスペルミジン、N8−アセチルスペルミジ
ンに対しては作用しない。(2) Substrate specificity: acts on acetylputretscine, but not on spermine, spermine, putretscine, N-acetylspermine, N1 -acetylspermidine, and N8 -acetylspermidine.
(3) 至適PH;8付近。(3) Optimum pH; around 8.
(4) PH安定性;PH6.0〜8.5において、37℃で30分
間加熱処理しても85%以上の残存活性を有す
る。(4) PH stability: At pH 6.0 to 8.5, it has a residual activity of 85% or more even after heat treatment at 37°C for 30 minutes.
(5) 至適温度;PH7.5において50℃付近。(5) Optimum temperature: around 50℃ at PH7.5.
(6) 温度安定性;PH7.0において40℃、30分処理
で90%残存活性がある。(6) Temperature stability: 90% residual activity after treatment at 40°C for 30 minutes at pH 7.0.
(7) 本酵素は銅を含有する。(7) This enzyme contains copper.
(8) 等電点;5.0付近。(8) Isoelectric point; around 5.0.
本酵素の基質に対する作用機序を反応式に示す
と次のようになる。 The mechanism of action of this enzyme on the substrate is shown in the reaction formula as follows.
アセチルプトレツシンオキシダーゼによるアセチ
ルポリアミンの分解反応式
アセチルプトレツシンオキシダーゼは、アセチ
ルポリアミンの中のアセチルプトレツシンのみに
作用し、等モル量のアンモニアと等モル量の過酸
化水素を生成するが、他のアセチルポリアミン及
び遊離ポリアミンには作用しない。Decomposition reaction formula of acetylpolyamine by acetylputrescine oxidase Acetylputrescine oxidase acts only on acetylputrescine among acetylpolyamines, producing equimolar amounts of ammonia and equimolar amounts of hydrogen peroxide, but does not act on other acetylpolyamines or free polyamines. .
本発明方法は、従来の方法では全く不可能であ
つたアセチルポリアミン類又はアセチルポリアミ
ン類と遊離ポリアミン類との混合系中に存在する
アセチルプトレツシンの濃度を直接定量するもの
である。 The method of the present invention directly determines the concentration of acetylputrescine present in acetylpolyamines or a mixed system of acetylpolyamines and free polyamines, which was completely impossible using conventional methods.
次に本発明の好適な実施態様を説明する。な
お、ここに示される酵素単位は、以下のようにし
て測定した1分間に1μmolの過酸化水素を生成す
るのに要する酵素量をもつて1単位として定めた
ものである。 Next, preferred embodiments of the present invention will be described. Note that the enzyme unit shown here is defined as one unit having the amount of enzyme required to produce 1 μmol of hydrogen peroxide per minute, which was measured as follows.
アセチルプトレツシンオキシダーゼの測定;
基質として10mMアセチルプトレツシン0.5ml
を、また発色液の緩衝液としてPH7.5の0.1Mリン
酸緩衝液をそれぞれ用いること以外は全て参考例
の場合と同様にして酵素活性を求める。 Measurement of acetylputretscine oxidase; 0.5ml of 10mM acetylputretscine as substrate
The enzyme activity is determined in the same manner as in the reference example except that 0.1M phosphate buffer with pH 7.5 is used as the buffer for the coloring solution.
本発明方法の好適な実施態様例においては、先
ずアセチルプトレツシンを含む試料に、アセチル
プトレツシンオキシダーゼ0.05〜0.5単位を添加
し、アセチルプトレツシンを酸化する。この反応
工程で生成する過酸化水素量を、fモルとすると
その量は次のように表わされる。 In a preferred embodiment of the method of the present invention, 0.05 to 0.5 units of acetylputrescine oxidase is first added to a sample containing acetylputretscine to oxidize the acetylputrescine. Assuming that the amount of hydrogen peroxide produced in this reaction step is f moles, the amount is expressed as follows.
f(モル)=(アセチルプトレツシンのモル数)
したがつて、アセチルプトレツシン濃度は
アセチルプトレツシン(μM)=K・f
ただし、K=1×10R6/分子吸光係数
本発明方法において過酸化水素量を測定するに
は、4−アミノアンチピリン/フエノール/ペル
オキシダーゼ系又は4−アミノアンチピリン/
N,N−ジエチルアニリン/ペルオキシダーゼ系
の試薬を用いる比色法のほか、過酸化水素の定量
に慣用されているけい光法、発光法などを用いる
こともできる。また、過酸化水素量を測定する代
りに、それに対応する酸素の減少量やアンモニ
ア、アルデヒドの増加量を測定することもでき
る。 f (moles) = (number of moles of acetylputretsucine) Therefore, the concentration of acetylputretsucine is Acetylputretsucine (μM) = K・f However, K = 1 × 10R 6 /molecular extinction coefficient Method of the present invention To measure the amount of hydrogen peroxide in a 4-aminoantipyrine/phenol/peroxidase system or 4-aminoantipyrine/
In addition to the colorimetric method using an N,N-diethylaniline/peroxidase-based reagent, it is also possible to use a fluorescence method, a luminescence method, etc., which are commonly used for quantifying hydrogen peroxide. Furthermore, instead of measuring the amount of hydrogen peroxide, it is also possible to measure the corresponding amount of decrease in oxygen or increase in ammonia or aldehyde.
本発明方法に従えば、従来のようにアセチルプ
トレツシンを測定するに当り、アセチルプトレツ
シンを塩酸や酵素で加水分解する操作は不用であ
り、高速液体クロマトグラフイー、アミノ酸分析
計など特殊な装置を用いる化学的方法でも非常に
困難とされていた。アセチルプトレツシンを迅
速、簡便かつ正確に測定することができるので、
本発明方法は、ガンその他の病気の診断や検査に
非常に有用である。 According to the method of the present invention, when measuring acetylputrethcine as in the past, there is no need to hydrolyze acetylputrethcine with hydrochloric acid or enzymes, and special methods such as high-performance liquid chromatography and amino acid analyzers are not required. Even chemical methods using modern equipment were considered extremely difficult. Because acetylputretscine can be measured quickly, easily, and accurately,
The method of the present invention is very useful for diagnosis and testing of cancer and other diseases.
次に参考例、実施例により本発明をさらに詳細
に説明する。 Next, the present invention will be explained in more detail with reference to Reference Examples and Examples.
参考例
ペルオキシダーゼ5mg、フエノール0.2ml、4
−アミノ−アンチピリン10mgをPH8.0の0.1Mリン
酸緩衝液に溶解し発色液を調製し、基質としてア
セチルプトレツシンを、また酵素としてアセチル
プトレツシンオキシダーゼ約0.5単位を用いて操
作を行つた。その結果を、第1図及び第2図にグ
ラフとして示す。このグラフから明らかなよう
に、反応は約5分以内に完了し、アセチルプトレ
ツシン1モルより1モルの過酸化水素が生成す
る。Reference example: peroxidase 5mg, phenol 0.2ml, 4
- Prepare a coloring solution by dissolving 10 mg of amino-antipyrine in 0.1M phosphate buffer at pH 8.0, and perform the operation using acetylputretscine as a substrate and about 0.5 units of acetylputrescine oxidase as an enzyme. Ivy. The results are shown in graphs in FIGS. 1 and 2. As is clear from this graph, the reaction is completed within about 5 minutes, and 1 mole of hydrogen peroxide is produced from 1 mole of acetylputrescine.
なお、参考例及び以下の実施例において用いた
各種アセチルポリアミンは「メソツズ・イン・エ
ンザイモロジー(Methods in Enzymology)」、
17B、第829〜833ページに記載された方法に従つ
て遊離ポリアミンより合成した。 In addition, the various acetyl polyamines used in the reference examples and the following examples are "Methods in Enzymology",
17B, pages 829-833 from free polyamines.
実施例 1
参考例と同様に、ペルオキシダーゼ5mg、フエ
ノール0.2ml、4−アミノアンチピリン10mgをPH
8.0の0.1Mリン酸緩衝液100mlに溶解して発色液
を調製した。Example 1 Similarly to the reference example, 5 mg of peroxidase, 0.2 ml of phenol, and 10 mg of 4-aminoantipyrine were added to PH.
A coloring solution was prepared by dissolving it in 100 ml of 0.1M phosphate buffer (8.0).
この発色液1.5mlとスペルミン、スペルミジン、
プトレツシン、アセチルスペルミン、N1−アセ
チルスペルミジン、N8−アセチルスペルミジン
及びアセチルプトレツシンのそれぞれの2.0mM
調製水溶液25μずつ及び蒸留水0.82mlを容量3
mlのセルに入れた。この溶液中のポリアミン類各
成分の濃度はいずれも20μMである。 1.5ml of this coloring liquid, spermine, spermidine,
2.0 mM each of putretzcine, acetylspermine, N 1 -acetylspermidine, N 8 -acetylspermidine and acetyl putretzine
3 volumes of 25 μ each of the prepared aqueous solution and 0.82 ml of distilled water
into a ml cell. The concentration of each polyamine component in this solution was 20 μM.
このように調製された溶液を35℃の温度で3分
間予熱後、この液にアセチルプトレツシンオキシ
ダーゼを5μ(約0.5単位)添加し、10分間反応
させたのち、505nmの吸光度を測定した。 After preheating the solution prepared in this manner at a temperature of 35° C. for 3 minutes, 5 μ (about 0.5 units) of acetylputrescine oxidase was added to the solution, and after reacting for 10 minutes, the absorbance at 505 nm was measured.
この値に基づいて、本発色液の分子吸光係数
6250を代入した定数Kを用い前記第一の実施態様
の各成分計算式から、アセチルプトレツシン濃度
を算出すると19.7μMであつた。 Based on this value, the molecular extinction coefficient of this coloring solution is
The acetylputrescine concentration was calculated from the formula for calculating each component in the first embodiment using the constant K in which 6250 was substituted and found to be 19.7 μM.
この値は、添加濃度値20.0μMと極めてよく一
致しており、本発明の方法が高い信頼性を有する
ことが理解されよう。 This value is in excellent agreement with the added concentration value of 20.0 μM, and it can be understood that the method of the present invention has high reliability.
実施例 2
ペルオキシダーゼ(ベーリンガー社グレード
)5.0mg、4−アミノアンチピリン10.0mg、ソ
ジウム−N−エチル−N−(2−ヒドロキシ−3
−スルホプロピル)−m−トルイジン54.8mgを
0.1Mリン酸緩衝液(PH8.0)100mlで溶解して調
製した発色液1.5mlと尿0.5mlと蒸留水0.5mlを3ml
セルに注入し、35℃で3分間予熱後、アセチルプ
トレツシンオキシダーゼ5μ(約0.5単位)を添
加し15分間反応後、555nmの吸光度を測定した。Example 2 Peroxidase (Boehringer grade) 5.0 mg, 4-aminoantipyrine 10.0 mg, sodium-N-ethyl-N-(2-hydroxy-3
-sulfopropyl)-m-toluidine 54.8mg
3 ml of 1.5 ml of coloring solution prepared by dissolving in 100 ml of 0.1M phosphate buffer (PH8.0), 0.5 ml of urine, and 0.5 ml of distilled water.
The mixture was injected into a cell, and after preheating at 35°C for 3 minutes, 5μ (approximately 0.5 unit) of acetylputrescine oxidase was added, and after reacting for 15 minutes, the absorbance at 555 nm was measured.
この反応によつて得られた吸光度変化量は次の
通りであつた。 The amount of change in absorbance obtained by this reaction was as follows.
吸光度変化量g=0.035
この値と本発色度による分子吸光係数17200を
用い、前記の実施態様の成分計算式に代入し計算
することにより反応液(2.5ml)中のアセチルプ
トレツシンの濃度は次のように算出された。 Absorbance change amount g = 0.035 Using this value and the molecular extinction coefficient of 17200 based on this color development, and substituting it into the component calculation formula of the above embodiment, the concentration of acetylputretsucine in the reaction solution (2.5 ml) is calculated. It was calculated as follows.
アセチルプトレツシン=1.74μM
この値から換算される尿水のアセチルプトレツ
シン濃度は次の通りである。 Acetylputretscine = 1.74 μM The acetylputretscine concentration in urine water converted from this value is as follows.
アセチルプトレツシン=8.7μM
実施例 3
実施例1と同じ組成成分を溶解して調製した発
色液1.5mlにスペルミン、スペルミジン、プトレ
ツシン、N1−アセチルスペルミジン、N8−アセ
チルスペルミジン、アセチルプトレツシンの各
2.0mM水溶液を50μずつ(最終的にはこれら各
既知成分の濃度はいずれも40μM)と管理用血清
液0.25ml(コーンセーラ「ニツスイ」1ビンを蒸
留水1.5mlで溶解したもの)と蒸留水0.45mlを3
mlセルに入れ、35℃で3分間予熱した。続いてア
セチルプトレツシンオキシダーゼ5μ(約0.5単
位)を添加し、10分間反応させたのち505nmの
吸光度を測定した吸光度変化量の測定値を代入し
て計算した結果アセチルプトレツシン:39.2μM
であつた。 Acetylputrescine = 8.7 μM Example 3 Add spermine, spermidine, putretzine, N 1 -acetylspermidine, N 8 -acetylspermidine, acetylputrescine to 1.5 ml of a coloring solution prepared by dissolving the same components as in Example 1. each of
50 μM each of a 2.0 mM aqueous solution (the final concentration of each of these known components is 40 μM), 0.25 ml of control serum (1 bottle of Corn Sera "Nitsui" dissolved in 1.5 ml of distilled water), and distilled water. 0.45ml 3
ml cell and preheated at 35°C for 3 minutes. Next, 5μ (approximately 0.5 units) of acetylputretscine oxidase was added, and after reacting for 10 minutes, the absorbance was measured at 505nm.The result was calculated by substituting the measured value of the absorbance change.Acetylputretscine: 39.2μM
It was hot.
本発明の定量法により測定されたアセチルプト
レツシンの濃度は、調製された各成分濃度40μM
とよく一致し、本発明方法が優れた実用的価値を
有することが確認される。 The concentration of acetylputretscine measured by the quantitative method of the present invention was 40 μM at each component concentration.
It is confirmed that the method of the present invention has excellent practical value.
実施例 4
参考例と同一組成の発色液を調製し、この発色
液1.5mlと、アセチルプトレツシンの各2.0mM水
溶液を100μ(最終的成分濃度は80μM)と蒸留
水0.90mlを3mlセルに入れ、35℃で3分間予熱
後、アセチルプトレツシンオキシダーゼを5μ
(約0.5単位)添加して約10分間反応させ、アセチ
ルプトレツシンの酸化によつて生じた過酸化水素
に基づく吸光度を測定した。この反応において得
られた工程の505nm吸光度変化量は0.528であつ
た。この値はアセチルプトレツシン81.9μMであ
り調製成分濃度とよく一致している。Example 4 A coloring solution with the same composition as the reference example was prepared, and 1.5ml of this coloring solution, 100μ of each 2.0mM aqueous solution of acetylputrethscine (final component concentration 80μM), and 0.90ml of distilled water were placed in a 3ml cell. After preheating at 35℃ for 3 minutes, add 5μ of acetylputrescine oxidase.
(approximately 0.5 unit) was added and reacted for approximately 10 minutes, and the absorbance based on hydrogen peroxide produced by oxidation of acetylputretscine was measured. The change in absorbance at 505 nm of the step obtained in this reaction was 0.528. This value was 81.9 μM for acetylputretscine, which is in good agreement with the concentration of the prepared components.
第1図及び第2図は、各アセチルプトレツシン
をそれぞれの成分にアセチルプトレツシン酸化酵
素を用いて酸化反応させた場合の時間と生成過酸
化水素に基づいて変化する吸光度との関係を示す
グラフである。
Figures 1 and 2 show the relationship between the absorbance that changes based on the time and hydrogen peroxide produced when each acetylputretscine is oxidized using acetylputretscine oxidase. This is a graph showing.
Claims (1)
プトレツシンオキシダーゼを作用させ、生成する
過酸化水素量を測定し、これに基づいてアセチル
プトレツシンの濃度を定量することを特徴とする
アセチルプトレツシンの定量方法。1. An acetylputretscine characterized by allowing acetylputretscine oxidase to act on a system containing acetylputretscine, measuring the amount of hydrogen peroxide produced, and quantifying the concentration of acetylputretscine based on this. Method for quantifying syn.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20834285A JPS6188897A (en) | 1985-09-20 | 1985-09-20 | Fractional determination of acetylputrescine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20834285A JPS6188897A (en) | 1985-09-20 | 1985-09-20 | Fractional determination of acetylputrescine |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57158848A Division JPS5948097A (en) | 1982-09-14 | 1982-09-14 | Fractionation and determination of polyamide and acetyl-polyamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6188897A JPS6188897A (en) | 1986-05-07 |
| JPS6338198B2 true JPS6338198B2 (en) | 1988-07-28 |
Family
ID=16554684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20834285A Granted JPS6188897A (en) | 1985-09-20 | 1985-09-20 | Fractional determination of acetylputrescine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6188897A (en) |
-
1985
- 1985-09-20 JP JP20834285A patent/JPS6188897A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6188897A (en) | 1986-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0921198B1 (en) | Method for enzymatically assaying saccharification protein | |
| JPH0646846A (en) | Fructosylamine deglycase, its production and method for determining amadori compound using the same enzyme | |
| Hersh et al. | A fluorometric assay for choline acetyltransferase and its use in the purification of the enzyme from human placenta | |
| Bhatia et al. | Electrochemical detection of interleukin-8 in human saliva using a polyenzyme label based on diaphorase and neutravidin | |
| Kohlbecker et al. | Direct spectrophotometric determination of serum and urinary oxalate with oxalate oxidase | |
| JPS6337639B2 (en) | ||
| Kojima et al. | An enzymatic method for the measurement of asparagine and a new assay of asparaginase activity | |
| JP2001190299A (en) | Method for examining preliminary group of diabetes mellitus | |
| JPH03251196A (en) | Method and composition for measuring l-carnitine in high sensitivity | |
| JPS6338198B2 (en) | ||
| JPH02195900A (en) | Determination of glycoprotein and determination reagent | |
| Tazuke et al. | A new enzymatic assay method of sulfated bile acids in urine | |
| Devlin | Enzymatic methods in analytical chemistry | |
| KR970001814B1 (en) | Process for measuring the content of component in vital fluid | |
| JPH064038B2 (en) | L-fucose quantification method | |
| JP2719709B2 (en) | Bile acid sulfate sulfatase, method for producing the same, and method for determining bile acid | |
| JP2000262299A (en) | Method for determining glucose by glucose dehydrogenase and reagent for determining glucose | |
| JP2761768B2 (en) | Method for determining NADH and method for determining bile acid using the same | |
| JP3007059B2 (en) | Method for determination of formaldehyde oxidase and substance or enzyme | |
| JPH02195899A (en) | Determination of glycoprotein and determination reagent | |
| JPS6057840B2 (en) | Cholesterol quantitative agent and method | |
| JPH09234098A5 (en) | ||
| US20220106621A1 (en) | System and method for detecting a target enzyme | |
| JPH09168397A (en) | Determination of sulfuric acid included bile acid and its kit | |
| JPH0242479B2 (en) |